FDA Clears Olastrocel Trial Expansion - Top-Institutions - MDSpire

FDA Clears Olastrocel Trial Expansion

Additional patients with ongoing opioid use are being enrolled as Creative Medical prepares for potential Phase 3 discussions with the FDA.

  • By

  • Kathryn Wighton

  • June 22, 2026

  • 3 min

Share

Top Institutions in Orthopedic Medicine

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

Original Source(s)

FDA Clears Olastrocel Trial Expansion

  • by Kathryn Wighton

  • June 22, 2026

Related Content

Emergency access to the subclavian vessels by non-thoracic surgeons: a cadaver-based learning model for orthopedic trauma surgery

Cadaver-based hands-on course in cervical spine surgery: a prospective evaluation of surgical confidence and self-perceived autonomy

Anterior Lumbar Interbody Fusion (ALIF): A Collaborative Approach to Spine Surgery

In this procedural case review, vascular surgeon Dr. Samuel Steerman and neurosurgeon Dr. Shannon Clark collaborate to perform an anterior lumbar interbody fusion (ALIF).

  • May 29, 2026

  • 1 min